Comparison between Cell Point IPO and Sonalis Consumer Products IPO.
IPO Details
Cell Point IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sonalis Consumer Products IPO is a SME Fixed Price proposed to list at BSE SME.
The total issue size of Cell Point IPO is up to ₹47.82 Cr whereas the issue size of the Sonalis Consumer Products IPO is up to ₹2.68 Cr. The final issue price of Cell Point IPO is ₹100.00 per share and of Sonalis Consumer Products IPO is ₹30.00 per share.
Cell Point IPO opens on Jun 15, 2023, while Sonalis Consumer Products IPO opens on Jun 07, 2023. The closing date of Cell Point IPO and Sonalis Consumer Products IPO is Jun 20, 2023, and Jun 09, 2023, respectively.
In the Cell Point IPO Retail Individual Investors (RII) are offered 23,91,000 shares while in Sonalis Consumer Products IPO retail investors are offered 23,91,000 shares. Qualified Institutional Buyers (QIB) are offered in Cell Point IPO and in Sonalis Consumer Products IPO.